 comparison continu versu sequenti estrogen progestin therapi postmenopaus women pilot studi efficaci safeti continu versu sequenti schedul prescrib medic ovarian hormon replac equin estrogen medroxyprogesteron acet bleed pattern endometri histolog metabol paramet postmenopaus women continu schedul daili estrogen progestin sequenti schedul estrogen day acet day dose mg conjug estrogen mg medroxyprogesteron acet bleed dosag conjug estrogen pattern similar schedul except amenorrhea preval women dosag estrogen continu progestin schedul frequent endometri atrophi continu schedul concept use schedul amenorrhea patient dose schedul modest insignific increas high-dens lipoprotein cholesterol sequenti therapi estrogen-induc decreas low-dens lipoprotein cholesterol continu schedul dosag conjug estrogen signific increas triglycerid continu sequenti schedul report continu schedul dosag medroxyprogesteron acet action lipid attent long-term effect dosag